Treatment of children with medulloblastoma without metastatic involvement in the age group older than 3 years: international experience and results of intercenter trial
Background. During the past 20 years, some large international studies have been conducted that evaluated the effectiveness of treatment programs for children with medulloblastoma. At the same time, in the standard risk group, fairly high rates of 5-year overall survival (OS) and event-free survival...
Main Authors: | Andrei S. Levashov, Svetlana R. Zagidullina, Anna M. Stroganova, Dmitrii A. Khochenkov, Marina V. Ryzhova, Sergei K. Gorelyshev, Shavkat U. Kadirov, Stepan S. Babelyan, Vasilii A. Grigorenko, Dmitrii A. Sidel’nikov, Natalia N. Subbotina, Vidmante V. Daylidite, Georgii L. Mentkevich |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IP Habib O.N.
2020-05-01
|
Series: | Современная онкология |
Subjects: | |
Online Access: | https://modernonco.orscience.ru/1815-1434/article/viewFile/34175/22587 |
Similar Items
-
Craniospinal dissemination of clival chondroid chordoma
by: Shinde S, et al.
Published: (2005-01-01) -
Recurrent craniospinal epidermoid: A case report
by: Abhidha Shah, et al.
Published: (2016-01-01) -
High-dose chemotherapy with hematopoietic stem cell rescuein children older than 3 year with medulloblastoma: results of single institution trial
by: S S Babelyan, et al.
Published: (2014-03-01) -
Assessment of Cerebrospinal Fluid Hydrodynamics Using Magnetic Resonance Imaging in Postcraniospinal Surgery Patients
by: Pankaj Arora, et al.
Published: (2021-04-01) -
Intracranial Ependymoma Follow-Up Study
by: J Gordon Millichap
Published: (1995-09-01)